Type 1 Diabetes Mellitus (T1DM)
16
4
6
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
6.3%
1 terminated out of 16 trials
83.3%
-3.2% vs benchmark
19%
3 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (16)
The Effect of Hedia Diabetes Assistant on TiMe-in-range in People With Type 1 Diabetes and Sub-Optimal Glycemic Control in France - A Randomised Controlled Trial.
Psychological Factors and Self-Care Behaviors in Spanish Youth With Type 1 Diabetes: Age- and Sex-Based Comparisons and Associations
Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
Pediatric Insulin Plan Calculator for T1DM Management
Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise
Thai PainPREDICT Validation Study
Clinical Study: Analysis of Glycemic Control and Satisfaction With a Connected Smart Cap in Patients With Type 1 Diabetes Mellitus
Semaglutide Treatment in Type 1 Diabetes
Cardiovascular Risk in Children With Chronic Conditions Study
Digital Tracking With Auto Data Reporting
Structured Education Program and Glycemic Control in Adolescents With Type 1 Diabetes
Prospective Cohort Study of Children Diagnosed with Type 1 Diabetes in Türkiye Between 2018 to 2022
Physical, Psychological and Socioeconomic Effects of Childhood Onset Diabetes in Sweden
Motivational Interviewing and WhatsApp-Based Monitoring for Metabolic Control and Self-Efficacy in Adolescents With T1DM
Evaluation of Pharmacokinetics , Safety, Tolerability and Pharmacodynamics of Biocon Insulin Tregopil
A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone